Showing results (571-580 of 843) with videos related to
Sort By:
Pageof 85
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymusM L Markert, D D Kostyu, F E Ward, et al.Plos One|June 15, 2016
Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8Cinque Soto, Gilad Ofek, M Gordon Joyce, et al.Journal of Virology|December 23, 2004
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoproteinFeng Gao, Eric A Weaver, Zhongjing Lu, et al.Immunohorizons|November 11, 2020
<i>RAB11FIP5</i>-Deficient Mice Exhibit Cytokine-Related Transcriptomic SignaturesDapeng Li, Todd Bradley, Derek W Cain, et al.Biorxiv : the Preprint Server for Biology|July 19, 2024
A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killingJoyce K Hwang, Daniel J Marston, Daniel Wrapp, et al.Virology|November 14, 2006
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteinsDenise L Kothe, Julie M Decker, Yingying Li, et al.Molecular Therapy. Nucleic Acids|April 12, 2019
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus MacaquesNorbert Pardi, Celia C LaBranche, Guido Ferrari, et al.Plos Pathogens|June 20, 2024
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Jaclyn S Higgins, et al.Journal of Virology|January 20, 2017
Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity ResponsesJérémie Prévost, Daria Zoubchenok, Jonathan Richard, et al.Vaccine|November 11, 2008
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trialPaul Spearman, Spyros Kalams, Marnie Elizaga, et al.Pageof 85